BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31324640)

  • 1. Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation.
    Jan M; Leventhal MJ; Morgan EA; Wengrod JC; Nag A; Drinan SD; Wollison BM; Ducar MD; Thorner AR; Leppanen S; Baronas J; Stevens J; Lane WJ; Kekre N; Ho VT; Koreth J; Cutler CS; Nikiforow S; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Lindsley RC; Ebert BL
    Blood Adv; 2019 Jul; 3(14):2199-2204. PubMed ID: 31324640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Escape of Relapsed AML Cells after Allogeneic Transplantation.
    Christopher MJ; Petti AA; Rettig MP; Miller CA; Chendamarai E; Duncavage EJ; Klco JM; Helton NM; O'Laughlin M; Fronick CC; Fulton RS; Wilson RK; Wartman LD; Welch JS; Heath SE; Baty JD; Payton JE; Graubert TA; Link DC; Walter MJ; Westervelt P; Ley TJ; DiPersio JF
    N Engl J Med; 2018 Dec; 379(24):2330-2341. PubMed ID: 30380364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploidentical
    Brissot E; Labopin M; Ehninger G; Stelljes M; Brecht A; Ganser A; Tischer J; Kröger N; Afanasyev B; Finke J; Elmaagacli A; Einsele H; Mohty M; Nagler A
    Haematologica; 2019 Mar; 104(3):524-532. PubMed ID: 30361416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of mismatched HLA in acute myeloid leukemia relapse after haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood: A case report.
    Han X; Zhao J; Liu J; Guo D; Li H; Fan S
    Transpl Immunol; 2022 Aug; 73():101602. PubMed ID: 35429620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT.
    Toffalori C; Cavattoni I; Deola S; Mastaglio S; Giglio F; Mazzi B; Assanelli A; Peccatori J; Bordignon C; Bonini C; Cortelazzo S; Ciceri F; Fleischhauer K; Vago L
    Blood; 2012 May; 119(20):4813-5. PubMed ID: 22596173
    [No Abstract]   [Full Text] [Related]  

  • 7. Loss of mismatched HLA detected in the peripheral blood of an AML patient who relapsed after haploidentical hematopoietic stem cell transplantation.
    Park BG; Sohn YH; Oh HB; Seo EJ; Jang S; Hong SP
    Ann Lab Med; 2015 Sep; 35(5):551-3. PubMed ID: 26206697
    [No Abstract]   [Full Text] [Related]  

  • 8. Loss of mismatched HLA in leukemia after stem-cell transplantation.
    Vago L; Perna SK; Zanussi M; Mazzi B; Barlassina C; Stanghellini MT; Perrelli NF; Cosentino C; Torri F; Angius A; Forno B; Casucci M; Bernardi M; Peccatori J; Corti C; Bondanza A; Ferrari M; Rossini S; Roncarolo MG; Bordignon C; Bonini C; Ciceri F; Fleischhauer K
    N Engl J Med; 2009 Jul; 361(5):478-88. PubMed ID: 19641204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct HLA Genetic Comparisons Identify Highly Matched Unrelated Donor-Recipient Pairs with Improved Transplantation Outcome.
    Vazirabad I; Chhabra S; Nytes J; Mehra V; Narra RK; Szabo A; Jerkins JH; Dhakal B; Hari P; Anderson MW
    Biol Blood Marrow Transplant; 2019 May; 25(5):921-931. PubMed ID: 30537549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia.
    Kharfan-Dabaja MA; Labopin M; Brissot E; Kroger N; Finke J; Ciceri F; Deconinck E; Blaise D; Chevallier P; Gramatzki M; Ganser A; Stelljes M; Edinger M; Savani B; Ruggeri A; Sanz J; Nagler A; Mohty M
    Br J Haematol; 2021 May; 193(3):592-601. PubMed ID: 33838047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide profiling in AML patients relapsing after allogeneic hematopoietic cell transplantation.
    Waterhouse M; Pfeifer D; Pantic M; Emmerich F; Bertz H; Finke J
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1450-1459.e1. PubMed ID: 21781950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.
    Boudreau JE; Giglio F; Gooley TA; Stevenson PA; Le Luduec JB; Shaffer BC; Rajalingam R; Hou L; Hurley CK; Noreen H; Reed EF; Yu N; Vierra-Green C; Haagenson M; Malkki M; Petersdorf EW; Spellman S; Hsu KC
    J Clin Oncol; 2017 Jul; 35(20):2268-2278. PubMed ID: 28520526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis.
    Doppelhammer M; Fraccaroli A; Prevalsek D; Bücklein V; Häbe S; Schulz C; Hubmann M; Hausmann A; Claus R; Rank A; Schmid C; Tischer J
    Ann Hematol; 2019 Mar; 98(3):753-762. PubMed ID: 30617644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.
    Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M
    Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation.
    Crucitti L; Crocchiolo R; Toffalori C; Mazzi B; Greco R; Signori A; Sizzano F; Chiesa L; Zino E; Lupo Stanghellini MT; Assanelli A; Carrabba MG; Marktel S; Marcatti M; Bordignon C; Corti C; Bernardi M; Peccatori J; Bonini C; Fleischhauer K; Ciceri F; Vago L
    Leukemia; 2015 May; 29(5):1143-52. PubMed ID: 25371177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
    Weisdorf DJ; Nelson G; Lee SJ; Haagenson M; Spellman S; Antin JH; Bolwell B; Cahn JY; Cervantes F; Copelan E; Gale R; Gratwohl A; Khoury HJ; McCarthy P; Marks DI; Szer J; Woolfrey A; Cortes-Franco J; Horowitz MM; Arora M;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1475-8. PubMed ID: 19822308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.
    How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation.
    Rovatti PE; Gambacorta V; Lorentino F; Ciceri F; Vago L
    Front Immunol; 2020; 11():147. PubMed ID: 32158444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.